Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation

NCT03546231 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-02-10

No results posted yet for this study

Summary

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

Conditions

  • Tricuspid Valve Disease

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Christophe TRIBOUILLOY, Pr · CHU AMIENS-PICARDIE

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-02
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03546231 on ClinicalTrials.gov